고분자 바이오 분석 검사 서비스 시장 규모, 점유율, 동향 분석 보고서 : 단계별, 검사별, 유형별, 치료 분야별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Large Molecule Bioanalytical Testing Services Market Growth & Trends:

The global large molecule bioanalytical testing services market size is expected to reach USD 3.70 billion by 2030, registering a CAGR of 9.63% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increased use of bioanalytical testing in clinical trials of biomarkers, large molecules, and other substances is the main driver of the industry. The rising incidence of chronic diseases and the rising demand for clinical trials in developing nations are the factors driving the market growth. For instance, according to the WHO, around 10 million people died from cancer in 2020. As per the estimates of cancer, 30.2 million people are likely to have cancer by 2040. Other factors that are anticipated to drive the segment growth include a rise in biologics, high demand for advanced technologies, and the need for personalized orphan drugs & medicines.

It is also projected that factors like technological advancement, globalization of clinical trials, and the rising need for CROs to perform clinical trials will accelerate industry expansion. Large pharmaceutical and bioanalytical firms, however, encountered difficulties as a result of the COVID-19 pandemic, which hampered clinical studies and treatments. Along with the workload of the COVID-19 project, which involves starting clinical trials, preclinical testing, doing bioanalysis, and interacting with regulatory bodies, other difficulties include the loss of workers at sites. The non-Covid initiatives were delayed, and there were lengthy 4-6 month wait times as a result of the resources being used to support the bioanalytical, preclinical, and clinical testing for the Covid trials. They must also resolve assays that are related to Covid and those that are not.

Large Molecule Bioanalytical Testing Services Market Report Highlights:

• The clinical phase segment dominated the market in 2024 with the largest revenue share of 66.6%. The growing prevalence of chronic diseases and increasing demand for clinical trials in developing countries are factors expected to drive segment growth.
• The global market is segmented into pharmacokinetics, Antidrug Antibodies (ADA), and others. The ADA segment accounted for the largest revenue share of the global market in 2024.
• The bioavailability segment held the largest revenue share in 2024. The segment growth can be attributed to the high demand for these services in generic drug manufacturing.
• Oncology accounted for a majority of revenue share in the global market in 2024. The segment is also anticipated to register the fastest CAGR during the forecast period.
• The SMEs segment dominated the global market in 2024. The segment is also anticipated to grow at the fastest CAGR over the forecast timeline, retaining its market dominance.
• North America large molecule bioanalytical testing services market dominated globally in 2024 with a revenue share of more than 48.94%.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Phase
  • 1.1.2. Type
  • 1.1.3. Test Type
  • 1.1.4. Therapeutic Area
  • 1.1.5. End Use
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Large Molecule Bioanalytical Testing Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Technological advancements in analytical testing
    • 3.2.1.2. Regulatory control and increasing awareness regarding bioanalytical testing
    • 3.2.1.3. Growing R&D expenditure in the pharmaceutical and biopharmaceutical industries
    • 3.2.1.4. Rising demand for outsourcing of analytical testing
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Compliance issues while outsourcing
    • 3.2.2.2. Data security concerns
• 3.3. R&D Investments & Funding Perspective
• 3.4. Clinical Trials Volume Analysis, (2023)
• 3.5. Pricing Model Analysis
• 3.6. Technology Landscape
• 3.7. Large Molecule Bioanalytical Testing Services Market Analysis Tools
  • 3.7.1. Porter's Five Forces Analysis
  • 3.7.2. PESTEL Analysis

Chapter 4. Large Molecule Bioanalytical Testing Services Market: Phase Estimates & Trend Analysis

• 4.1. Large Molecule Bioanalytical Testing Services Market, By Phase: Segment Dashboard
• 4.2. Global Large Molecule Bioanalytical Testing Services Market by Phase: Movement Analysis
• 4.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Phase, 2018 - 2030 (USD Million) for the following
• 4.4. Preclinical
  • 4.4.1. Preclinical market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.2. With Antibody
    • 4.4.2.1. With Antibody market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4.3. Without Antibody (ELISA Based Assay)
    • 4.4.3.1. Without Antibody (ELISA Based Assay) market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Clinical
  • 4.5.1. Clinical market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Large Molecule Bioanalytical Testing Services Market by Type Estimates & Trend Analysis

• 5.1. Large Molecule Bioanalytical Testing Services Market, By Type: Segment Dashboard
• 5.2. Global Large Molecule Bioanalytical Testing Services Market by Type: Movement Analysis
• 5.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Type, 2018 - 2030 (USD Million) for the following
• 5.4. Pharmacokinetics
  • 5.4.1. Pharmacokinetics market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. ADA
  • 5.5.1. ADA market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Large Molecule Bioanalytical Testing Services Market: Test Type Estimates & Trend Analysis

• 6.1. Large Molecule Bioanalytical Testing Services Market, By Test: Segment Dashboard
• 6.2. Global Large Molecule Bioanalytical Testing Services Market by Test Type: Movement Analysis
• 6.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Test Type, 2018 - 2030 (USD Million) for the following
• 6.4. ADME
  • 6.4.1. ADME market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. PD
  • 6.5.1. PD market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Bioavailability
  • 6.6.1. Bioavailability market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.7. Bioequivalence
  • 6.7.1. Bioequivalence market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.8. Other Tests
  • 6.8.1. Other tests market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Large Molecule Bioanalytical Testing Services Market by Therapeutic Area Estimates & Trend Analysis

• 7.1. Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area: Segment Dashboard
• 7.2. Global Large Molecule Bioanalytical Testing Services Market by Therapeutic Area: Movement Analysis
• 7.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030 (USD Million) for the following
• 7.4. Oncology
  • 7.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.5. Infectious Diseases
  • 7.5.1. Infectious Diseases market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.6. Cardiology
  • 7.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.7. Neurology
  • 7.7.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.8. Others
  • 7.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Large Molecule Bioanalytical Testing Services Market by End Use Estimates & Trend Analysis

• 8.1. Large Molecule Bioanalytical Testing Services Market, By End Use: Segment Dashboard
• 8.2. Global Large Molecule Bioanalytical Testing Services Market by End Use: Movement Analysis
• 8.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million) for the following
• 8.4. SMEs
  • 8.4.1. SMEs market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.2. CROs & CMOs
    • 8.4.2.1. CROs & CMOs market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.3. Sponsor Organizations
    • 8.4.3.1. Sponsor Organizations market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4.4. Others
    • 8.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.5. Large Firms
  • 8.5.1. Large Firms market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.2. CROs & CMOs
    • 8.5.2.1. CROs & CMOs market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.3. Sponsor Organizations
    • 8.5.3.1. Sponsor Organizations market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5.4. Others
    • 8.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Large Molecule Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis

• 9.1. Regional market share analysis, 2024 & 2030
• 9.2. Regional Market Dashboard
• 9.3. North America
  • 9.3.1. MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Competitive Scenario
    • 9.3.2.3. Regulatory Framework
    • 9.3.2.4. U.S. large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Competitive Scenario
    • 9.3.3.3. Regulatory Framework
    • 9.3.3.4. Canada large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Competitive Scenario
    • 9.3.4.3. Regulatory Framework
    • 9.3.4.4. Mexico large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Competitive Scenario
    • 9.4.2.3. Regulatory Framework
    • 9.4.2.4. UK large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Competitive Scenario
    • 9.4.3.3. Regulatory Framework
    • 9.4.3.4. Germany large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Competitive Scenario
    • 9.4.4.3. Regulatory Framework
    • 9.4.4.4. France large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Competitive Scenario
    • 9.4.5.3. Regulatory Framework
    • 9.4.5.4. Italy large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Competitive Scenario
    • 9.4.6.3. Regulatory Framework
    • 9.4.6.4. Spain large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Competitive Scenario
    • 9.4.7.3. Regulatory Framework
    • 9.4.7.4. Denmark large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Competitive Scenario
    • 9.4.8.3. Regulatory Framework
    • 9.4.8.4. Sweden large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Competitive Scenario
    • 9.4.9.3. Regulatory Framework
    • 9.4.9.4. Norway large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competitive Scenario
    • 9.5.2.3. Regulatory Framework
    • 9.5.2.4. Japan large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competitive Scenario
    • 9.5.3.3. Regulatory Framework
    • 9.5.3.4. China large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competitive Scenario
    • 9.5.4.3. Regulatory Framework
    • 9.5.4.4. India large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.5.5. Thailand
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Competitive Scenario
    • 9.5.5.3. Regulatory Framework
    • 9.5.5.4. Thailand large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.5.6. South Korea
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Competitive Scenario
    • 9.5.6.3. Regulatory Framework
    • 9.5.6.4. South Korea large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.5.7. Australia
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Competitive Scenario
    • 9.5.7.3. Regulatory Framework
    • 9.5.7.4. Australia large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competitive Scenario
    • 9.6.2.3. Regulatory Framework
    • 9.6.2.4. Brazil large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competitive Scenario
    • 9.6.3.3. Regulatory Framework
    • 9.6.3.4. Argentina large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.6.4. Colombia
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. Competitive Scenario
    • 9.6.4.3. Regulatory Framework
    • 9.6.4.4. Colombia large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
• 9.7. MEA
  • 9.7.1. MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Regulatory Framework
    • 9.7.2.4. South Africa large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Regulatory Framework
    • 9.7.3.4. Saudi Arabia large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Regulatory Framework
    • 9.7.4.4. UAE large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Competitive Scenario
    • 9.7.5.3. Regulatory Framework
    • 9.7.5.4. Kuwait large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Categorization
• 10.2. Market Leaders
• 10.3. Emerging Players
• 10.4. Market Position Analysis, 2024
• 10.5. Company Profiles
  • 10.5.1. Laboratory Corporation of America Holdings
    • 10.5.1.1. Company overview
    • 10.5.1.2. Financial Performance
    • 10.5.1.3. Service benchmarking
    • 10.5.1.4. Strategic initiatives
  • 10.5.2. IQVIA
    • 10.5.2.1. Company overview
    • 10.5.2.2. Financial performance
    • 10.5.2.3. Service benchmarking
    • 10.5.2.4. Strategic initiatives
  • 10.5.3. Syneous Health
    • 10.5.3.1. Company overview
    • 10.5.3.2. Financial performance
    • 10.5.3.3. Service benchmarking
    • 10.5.3.4. Strategic initiatives
  • 10.5.4. SGS, SA
    • 10.5.4.1. Company overview
    • 10.5.4.2. Financial performance
    • 10.5.4.3. Service benchmarking
    • 10.5.4.4. Strategic initiatives
  • 10.5.5. WuXi AppTec
    • 10.5.5.1. Company overview
    • 10.5.5.2. Financial performance
    • 10.5.5.3. Service benchmarking
    • 10.5.5.4. Strategic initiatives
  • 10.5.6. Intertek Plc
    • 10.5.6.1. Company overview
    • 10.5.6.2. Financial performance
    • 10.5.6.3. Service benchmarking
    • 10.5.6.4. Strategic initiatives
  • 10.5.7. Pace Analytical Services LLC
    • 10.5.7.1. Company overview
    • 10.5.7.2. Financial performance
    • 10.5.7.3. Service benchmarking
    • 10.5.7.4. Strategic initiatives
  • 10.5.8. ICON PLC
    • 10.5.8.1. Company overview
    • 10.5.8.2. Financial performance
    • 10.5.8.3. Service benchmarking
    • 10.5.8.4. Strategic initiatives
  • 10.5.9. Charles River Laboratories
    • 10.5.9.1. Company overview
    • 10.5.9.2. Financial performance
    • 10.5.9.3. Service benchmarking
    • 10.5.9.4. Strategic initiatives
  • 10.5.10. ThermoFisher Scientific
    • 10.5.10.1. Company overview
    • 10.5.10.2. Financial performance
    • 10.5.10.3. Service benchmarking
    • 10.5.10.4. Strategic initiatives